Upstream Bio (UPB) Interest Expenses (2023 - 2026)

Upstream Bio's Interest Expenses history runs 4 years deep, the most recent figure standing at $21.2 million for Q1 2026.

• On a quarterly basis, Interest Expenses rose 179.53% year-over-year to $21.2 million in Q1 2026; TTM through Mar 2026 was $21.2 million, a 179.53% increase from a year earlier, with the FY2025 full-year figure at $162.3 million, up 127.71% from the prior year.
• Interest Expenses eased to $21.2 million in Q1 2026 per UPB's latest filing, from $162.3 million in the prior quarter.
• Across five years, Interest Expenses topped out at $162.3 million in Q4 2025 and bottomed at $7.6 million in Q1 2025.
• The 4-year median for Interest Expenses is $39.7 million (2023), against an average of $59.5 million.
• Across the five-year window, Interest Expenses surged 79.53% in 2024 and jumped 183.66% in 2025, its largest moves.
• Year by year, Interest Expenses stood at $39.7 million in 2023, then jumped by 79.53% to $71.3 million in 2024, then soared by 127.71% to $162.3 million in 2025, then sank by 86.92% to $21.2 million in 2026.
• Per Business Quant, the three latest UPB Interest Expenses figures stand at $21.2 million (Q1 2026), $162.3 million (Q4 2025), and $99.5 million (Q3 2025).